View on Pubmed.gov 16702488 | View on doi.org 10.1161/CIRCULA...
Biomarkers of cardiovascular disease: molecular basis and practical considerations.
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Department of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, MA, USA. vasan@bu.edu
Abstract
References
Cited by 1157 citations (total)
Journal Article Comment
Circulating ACE2: a novel biomarker of cardiovascular risk.
Electronic publication date October 10, 2020
Jay Ramchand [...] Louise M Burrell et al.
Journal Article
Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients.
Electronic publication date January 1, 2007
José A Páramo [...] Josune Orbe et al.
The clinical utility of a biomarker depends on its ability to identify high-risk individuals to optimally manage the patient. A...
Conflict of interest statement
MeSH
- •
- •
- •
Specialties
Substances
- •